These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Reddel RR; Murphy LC; Sutherland RL Cancer Res; 1984 Jun; 44(6):2398-405. PubMed ID: 6722780 [TBL] [Abstract][Full Text] [Related]
5. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen. Morrissey JJ; Raney S Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849 [TBL] [Abstract][Full Text] [Related]
6. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens. Butler WB; Kelsey WH; Goran N Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631 [TBL] [Abstract][Full Text] [Related]
7. [125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity label. Salituro FG; Carlson KE; Elliston JF; Katzenellenbogen BS; Katzenellenbogen JA Steroids; 1986; 48(5-6):287-313. PubMed ID: 3445283 [TBL] [Abstract][Full Text] [Related]
8. Iodine-125 cytotoxicity: implications for therapy and estimation of radiation risk. Bloomer WD; Adelstein SJ Int J Nucl Med Biol; 1981; 8(2-3):171-8. PubMed ID: 7033155 [No Abstract] [Full Text] [Related]
9. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Fisher B; Jeong JH; Bryant J; Anderson S; Dignam J; Fisher ER; Wolmark N; Lancet; 2004 Sep 4-10; 364(9437):858-68. PubMed ID: 15351193 [TBL] [Abstract][Full Text] [Related]
10. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines]. Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630 [TBL] [Abstract][Full Text] [Related]
11. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer. Toko T; Shibata J; Nukatsuka M; Yamada Y Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952 [TBL] [Abstract][Full Text] [Related]
12. Target size analysis of estrogen receptor in cultured intact cells: change in receptor structure between subconfluency and superconfluency in culture. Toulas C; Beauregard G; Delassus F; Thauvette L; Potier M; Bayard F; Faye JC Mol Cell Endocrinol; 1990 Aug; 72(2):89-94. PubMed ID: 2282975 [TBL] [Abstract][Full Text] [Related]
13. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652 [TBL] [Abstract][Full Text] [Related]
14. Antagonism between tamoxifen and doxorubicin in the MCF-7 human breast tumor cell line. Woods KE; Randolph JK; Gewirtz DA Biochem Pharmacol; 1994 Apr; 47(8):1449-52. PubMed ID: 8185652 [TBL] [Abstract][Full Text] [Related]
15. [Tamoxifen induced fluorescence as a marker of hormone receptors: cytological study of fine needle biopsy of malignant breast tumors in treated women]. Mouriquand J; Mouriquand C; Sage JC; Saez S; Jacrot M; Gabelle P C R Seances Acad Sci III; 1981 Dec; 293(15):801-6. PubMed ID: 6804016 [TBL] [Abstract][Full Text] [Related]
16. A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological role. Brandes LJ Biochem Biophys Res Commun; 1984 Oct; 124(1):244-9. PubMed ID: 6548626 [TBL] [Abstract][Full Text] [Related]
17. Effects of Electroporation on Tamoxifen Delivery in Estrogen Receptor Positive (ER+) Human Breast Carcinoma Cells. Esmekaya MA; Kayhan H; Yagci M; Coskun A; Canseven AG Cell Biochem Biophys; 2017 Mar; 75(1):103-109. PubMed ID: 27981422 [TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen. Boylan M; van den Berg HW; Lynch M Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667 [TBL] [Abstract][Full Text] [Related]
19. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA; Lippman ME; Katzenellenbogen BS Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [TBL] [Abstract][Full Text] [Related]
20. Biochemistry of tamoxifen therapy in breast cancer. Nicholson RI Biochem Soc Trans; 1979 Jun; 7(3):569-72. PubMed ID: 446863 [No Abstract] [Full Text] [Related] [Next] [New Search]